Ophir Avinoam, Hanna Rana, Martinez Michael R
Division of Ophthalmology, Hillel-Yaffe Medical Center, Hadera 31800, Israel ; The Ruth and Bruce Rappaport Faculty of Medicine, the Technion, Haifa 3200003, Israel.
Division of Ophthalmology, Hillel-Yaffe Medical Center, Hadera 31800, Israel.
Int J Ophthalmol. 2013 Dec 18;6(6):836-43. doi: 10.3980/j.issn.2222-3959.2013.06.17. eCollection 2013.
To present the outcome of modified grid laser photocoagulation (GLP) in diffuse diabetic macular edema (DDME) in eyes without extrafoveal and/or vitreofoveal traction.
Inclusion criteria for the retrospective study were DDME eyes of patients with type II diabetes mellitus that had ≥4 months of follow-up following GLP. Only one eye per patient was analyzed. Using 3-D spectral-domain optical coherence tomography (3-D SD-OCT), eyes that had either extrafoveal or vitreofoveal traction, or had been previously treated by an intravitreal medication(s) were excluded. Treated DDME eyes were divided into 4 groups: A) "Classic" DDME that involved the central macula; B) edema did not involve the macular center; C) eyes associated with central epiretinal membrane (ERM); D) DDME that was associated with macular capillary dropout ≥2 disc-diameter (DD).
GLP outcome in 35 DDME eyes after 4-24 (mean, 13.1±6.9) months was as follows: Group A) 18 eyes with "classic" DDME. Following one or 2 (mean, 1.2) GLP treatments, best-corrected visual acuity (BCVA) improved by 1-2 Snellen lines in 44.4% (8/18) of eyes, and worsened by 1 line in 11.1% (2/18). Central macular thickness (CMT) improved by 7%-49% (mean, 26.6%) in 77.8% (14/18) of eyes. Causes of CMT worsening (n=4) were commonly explainable, predominantly (n=3) associated with emergence of extrafoveal traction, 5-9 months post-GLP. Group B) GLP(s) in DDME that did not involve the macular center (n=6) resulted in improved BCVA by 1-2 lines in 2 eyes. However, the central macula became involved in the edema process after the GLP in 3 (50%) eyes, associated with an emergence of extrafoveal traction in one of these eyes 4 months following the GLP. Group C) GLP failed in all 5 eyes associated with central ERM. Group D) GLP was of partial benefit in 2 of 6 treated eyes with macular capillary dropout ≥2DD.
Eyes with DDME that involved the macular center were found to achieve favourable outcomes after GLP(s) during mid-term follow-up, unless complicated pre-GLP or post-GLP by vitreoretinal interface abnormalities, often extrafoveal traction or ERM, or by capillary dropout ≥2DD. Prospective studies with larger cohorts are required.
呈现改良格栅激光光凝术(GLP)治疗无黄斑外和/或玻璃体黄斑牵拉的糖尿病性黄斑水肿(DDME)的疗效。
本回顾性研究的纳入标准为II型糖尿病患者的DDME眼,这些眼在接受GLP治疗后有≥4个月的随访。每位患者仅分析一只眼。使用三维光谱域光学相干断层扫描(3-D SD-OCT),排除有黄斑外或玻璃体黄斑牵拉,或曾接受玻璃体内药物治疗的眼。接受治疗的DDME眼分为4组:A)累及黄斑中心的“典型”DDME;B)水肿未累及黄斑中心;C)伴有中心视网膜前膜(ERM)的眼;D)与黄斑毛细血管闭塞≥2视盘直径(DD)相关的DDME。
35只DDME眼在4 - 24(平均13.1±6.9)个月的GLP治疗后的结果如下:A组)18只“典型”DDME眼。在接受1或2次(平均1.2次)GLP治疗后,44.4%(8/18)的眼最佳矫正视力(BCVA)提高了1 - 2行,11.1%(2/18)的眼视力下降了1行。77.8%(14/18)的眼中黄斑中心厚度(CMT)改善了7% - 49%(平均26.6%)。CMT恶化的原因(n = 4)通常可以解释,主要(n = 3)与GLP治疗后5 - 9个月黄斑外牵拉的出现有关。B组)未累及黄斑中心的DDME(n = 6)接受GLP治疗后,2只眼的BCVA提高了1 - 2行。然而,在3只(50%)眼中,GLP治疗后黄斑中心出现水肿,其中1只眼在GLP治疗后4个月出现黄斑外牵拉。C组)所有5只伴有中心ERM的眼GLP治疗均失败。D组)在6只接受治疗的黄斑毛细血管闭塞≥2DD的眼中,2只眼的GLP治疗有部分益处。
发现累及黄斑中心的DDME眼在中期随访期间接受GLP治疗后可取得良好疗效,除非GLP治疗前或治疗后并发玻璃体视网膜界面异常,通常为黄斑外牵拉或ERM,或毛细血管闭塞≥2DD。需要进行更大样本量的前瞻性研究。